Delivery Order SPE2DR25D3303-SPE2DR26F61C8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,163.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Synthroid 150 micrograms tablets in quantities of 1,000 units. This competitive award, valued at $1,308.24, represents a firm fixed price delivery order with an ultimate completion date of October 29, 2025. The contract is performed at the contractor's facility in Conshohocken, Pennsylvania, and carries no set-aside designation. This award is issued as a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.37 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,808.16 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 micrograms on October 22, 2025, with completion scheduled for October 23, 2025. This competitive, non-set-aside award uses firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the vendor's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on October 28, 2025, for the supply of 1,000 tablets of Synthroid 50 micrograms at a ceiling value of $2,191.45. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of October 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms at a ceiling value of $2,134.25. This is a firm fixed-price delivery order with no set-aside designation, completed by July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a competitive procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,231.14 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 mcg. This firm fixed-price delivery order, issued on September 17, 2025, with completion targeted for September 18, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Synthroid 50 MCG tablets (1,000-unit quantity) valued at $1,355.36. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- This delivery order, valued at $6,272.87, was awarded by the Defense Logistics Agency (DLA) on November 12, 2025, to AmerisourceBergen Drug Corp for the supply of Synthroid 25 MCG tablets in quantities of 1,000 units. The contract utilizes firm fixed pricing and is not subject to any set-aside designation, indicating it was competitively awarded. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F61C8Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,434.79 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 MCG on November 13, 2025, with completion scheduled for November 14, 2025. This is a non-set-aside competitive award performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical and medical products to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's delivery orders under this vehicle demonstrate its capability to fulfill diverse pharmaceutical supply needs, ranging from specialty medications and brand-name drugs to generic pharmaceuticals and medical devices. As a child contract under the larger SPE2DX prime vendor agreement, this Synthroid order exemplifies the routine pharmaceutical resupply operations that sustain military medical readiness across federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/13/25 |